Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRAH

PRA Health Sciences (PRAH) Stock Price, News & Analysis

PRA Health Sciences logo

About PRA Health Sciences Stock (NASDAQ:PRAH)

Advanced Chart

Key Stats

Today's Range
$165.21
$165.21
50-Day Range
$165.21
$174.52
52-Week Range
$93.00
$175.95
Volume
57 shs
Average Volume
837,472 shs
Market Capitalization
$10.70 billion
P/E Ratio
50.52
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PRA Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

PRAH Stock News Headlines

PRA Health Sciences
The Private Market Surge Is Coming in 2025
The most lucrative investment opportunities are reserved for a select category of investor. They're private. They're quiet. And they're often available exclusively to accredited investors operating outside the noise of the public markets. We're talking about off-market placements, early venture deals, private credit, and pre-IPO shares—the kind of plays that can generate outsized gains before Wall Street catches wind. Here's the reality: having access is only the beginning. These deals can be opaque, rushed, and filled with hidden risk. That's why we created something exclusively for investors like you—the 2025 Accredited Investor Playbook.
PRAH Historical Data
Western University of Health Sciences
Mercy College of Health Sciences
See More Headlines

PRAH Stock Analysis - Frequently Asked Questions

PRA Health Sciences, Inc. (NASDAQ:PRAH) released its quarterly earnings data on Wednesday, April, 28th. The medical research company reported $1.35 EPS for the quarter, topping analysts' consensus estimates of $1.32 by $0.03. The firm's revenue was up 19.1% on a year-over-year basis.

PRA Health Sciences (PRAH) raised $306 million in an initial public offering (IPO) on Thursday, November 13th 2014. The company issued 17,000,000 shares at $18.00 per share. Jefferies, Citigroup, KKR, UBS Investment Bank, Credit Suisse and Wells Fargo Securities served as the underwriters for the IPO and Baird and William Blair were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that PRA Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Visa (V) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
4/28/2021
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Commercial Physical Research
Sub-Industry
N/A
Current Symbol
NASDAQ:PRAH
CIK
1613859
Fax
N/A
Employees
18,100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$3.90
Trailing P/E Ratio
50.52
Forward P/E Ratio
31.29
P/E Growth
N/A
Net Income
$197.04 million
Net Margins
6.40%
Pretax Margin
N/A
Return on Equity
20.49%
Return on Assets
7.07%

Debt

Debt-to-Equity Ratio
0.74
Current Ratio
1.21
Quick Ratio
1.21

Sales & Book Value

Annual Sales
$3.18 billion
Price / Sales
3.36
Cash Flow
$6.09 per share
Price / Cash Flow
27.11
Book Value
$23.06 per share
Price / Book
7.16

Miscellaneous

Outstanding Shares
64,795,000
Free Float
N/A
Market Cap
$10.70 billion
Optionable
Optionable
Beta
1.31

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:PRAH) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners